Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.69 |
| ▸ | CCR2 | P41597 | 1/20 | 0.53 |
| ▸ | RHEB | Q15382 | 3/20 | 0.53 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | DRD2 | P14416 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | SLCO2B1 | O94956 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.48 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.48 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.48 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19137965 | 0.86 | DGAT1 (0.63) | CCR2RHEBSMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL19137938 | 0.85 | NPBWR1 (0.59) | ACHECCR2RHEBSMN1; SMN2ALDH1A1 | |
| SCHEMBL19137947 | 0.84 | CCR2 (0.58) | ACHECCR2RHEBSMN1; SMN2ALDH1A1 | |
| SCHEMBL19137933 | 0.83 | RHEB (0.58) | ACHECCR2RHEBSMN1; SMN2ALDH1A1 | |
| SCHEMBL6361354 | 0.80 | TOP1 (0.73) | ACHESMN1; SMN2ALDH1A1MAPTKMT2A | |
| SCHEMBL19175932 | 0.79 | DGAT1 (0.59) | ACHESMN1; SMN2ALDH1A1MAPTKMT2A | |
| SCHEMBL19167944 | 0.78 | NPBWR1 (0.55) | ACHECCR2RHEBSMN1; SMN2ALDH1A1 | |
| SCHEMBL19137939 | 0.78 | DGAT1 (0.61) | ACHESMN1; SMN2ALDH1A1MAPTKMT2A | |
| SCHEMBL19166950 | 0.77 | SIRT2 (0.55) | ACHECCR2RHEBSMN1; SMN2ALDH1A1 | |
| SCHEMBL31592849 | 0.76 | DRD2 (0.56) | ACHESMN1; SMN2DRD2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170210741-A1 | Benzimidazole Compounds, Use As Inhibitors of WNT Signaling Pathway in Cancers, and Methods for Preparation Thereof | SOUTHERN RESEARCH INSTITUTE | 2017-07-27 | — | — | US | disclosed |
| US-20170210741-A1 | Benzimidazole Compounds, Use As Inhibitors of WNT Signaling Pathway in Cancers, and Methods for Preparation Thereof | SOUTHERN RESEARCH INSTITUTE | 2017-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170210741-A1 | Benzimidazole Compounds, Use As Inhibitors of WNT Signaling Pathway in Cancers, and Methods for Preparation Thereof | WNT1, WNT3, CTNNB1 | ACHE 3338/4885CCR2 4388/4885RHEB 1379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.